Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation

New England Journal of Medicine

Volumn 327, Issue 26, 1992, Pages 1832-1835

  Czeizel, Andrew E ^a   Dudás, István ^a  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; COPPER; CYANOCOBALAMIN; FOLIC ACID; MANGANESE; MULTIVITAMIN; NICOTINAMIDE; PANTOTHENATE CALCIUM; PHOSPHORUS; PYRIDOXINE; RETINOL; RIBOFLAVIN; THIAMINE; VITAMIN D; ZINC;

ADULT; ARTICLE; CLEFT LIP; CLEFT PALATE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; NEURAL TUBE DEFECT; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; SUPPLEMENTATION;

ABNORMALITIES; CLEFT LIP; FEMALE; FOLIC ACID; HUMAN; NEURAL TUBE DEFECTS; PARITY; PRECONCEPTION CARE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; TRACE ELEMENTS; VITAMINS;

EID: 0027080461     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199212243272602     Document Type: Article

References (17)

1. Smithells RW, Sheppard S, Schorah CJ, et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980; 1: 339–40.
2. Smithells RW, Sheppard S, Wild J, Schorah CJ. Prevention of neural tube defect recurrences in Yorkshire: final report. Lancet 1989; 2: 498–9.
3. Laurence KM, James M, Miller MH, Tennant GB, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ 1981; 282: 1509–11.
4. Vergel RG, Sanchez LR, Heredero BL, Rodriguez PL, Martinez AJ. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 1990; 10: 149–52.
5. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131–7.
6. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988; 260: 3141–5.
7. Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989; 262: 2847–52.
8. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: evidence from a case–control study in Western Australia. Med J Aust 1989; 150: 613–9.
9. Bower. Periconceptional vitamin supplementation and neural tube defects: evidence from a case–control study in Western Australia and a review of recent publications. J Epidemiol Community Health 1992; 46: 157–61.
10. Mills JL, Rhoads GG, Simpson JL, et al. The absence of a relation between the periconceptional use of vitamins and neural-tube defects. N Engl J Med 1989; 321: 430–5.
11. Czeizel A. Medical genetics in Hungary. J Med Genet 1988; 25: 2–8.
12. Dudás I, Czeizel AE. Use of 6,000 IU vitamin A during early pregnancy without teratogenic effect. Teratology 1992; 45: 335–6.
13. Czeizel A, Telegdi L, Tusnády G. Multiple congenital abnormalities. Budapest, Hungary: Akadémiai Kiadó, 1988.
14. Czeizel A, Révész C. Major malformations cf the central nervous system in Hungary. Br J Prev Soc Med 1970; 24: 205–22.
15. Czeizel AE, Dudás I, Fritz G, Técsöi A, Hanck A, Kunovits G. The effect of periconceptual multivitamin-mineral supplementation on vertigo, nausea, and vomiting in the first trimester of pregnancy. Arch Gynecol Obstet 1992; 251: 181–5.
16. Czeizel A, Tusnády G. Aetiological studies of isolated common congenital abnormalities in Hungary. Eliás L, trans. Budapest, Hungary: Akadémiai Kiadó, 1984.
17. Tolarova M. Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip. Lancet 1982; 2: 217.